Pratima Chowdary
Overview
Explore the profile of Pratima Chowdary including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
111
Citations
3115
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chowdary P, Carcao M, Kenet G, Pipe S
Lancet
. 2025 Mar;
405(10480):736-750.
PMID: 40023652
Haemophilia A and B are congenital X-linked bleeding disorders resulting from deficiencies in clotting factors VIII (haemophilia A) and IX (haemophilia B). Patients with severe deficiency, defined as having less...
2.
Lentz S, Chowdary P, Gil L, Lopez-Jaime F, Mahlangu J, Matytsina I, et al.
J Thromb Haemost
. 2025 Feb;
PMID: 39984358
No abstract available.
3.
Miesbach W, Batty P, Chowdary P, Fong S, Kaczmarek R, Leebeek F, et al.
Res Pract Thromb Haemost
. 2025 Feb;
9(1):102673.
PMID: 39895992
Adeno-associated virus-based gene therapy for hemophilia has emerged as a revolutionary treatment option, offering potential correction of clotting factor deficiency through a single intravenous infusion of functional genes directed to...
4.
Kamel K, Sardo Infirri S, Riddell A, Chowdary P, Batty P
Haemophilia
. 2025 Jan;
PMID: 39812462
Background: Acquired haemophilia A (AHA) is an acquired bleeding disorder resulting from autoantibodies against Factor VIII (FVIII). Previous studies have reported differences in FVIII inhibitor kinetics (type I or type...
5.
Skinner M, Albisetti M, Ardila J, Astermark J, Blatny J, Carcao M, et al.
Haemophilia
. 2024 Dec;
PMID: 39648854
Introduction: The 2024 ISTH clinical practice guideline (CPG) for treatment of congenital haemophilia, the NBDF-McMaster Guideline on Care Models for Haemophilia Management, and ASH ISTH NBDF WFH guidelines on the...
6.
Pipe M.D S, Pipe S, Lissitchkov T, Lissitchkov T, Georgiev P, Mangles S, et al.
Blood Adv
. 2024 Dec;
9(5):1147-1158.
PMID: 39642315
Fitusiran is an investigational small interfering RNA therapeutic that targets antithrombin (AT) to rebalance hemostasis in people with hemophilia. Here, we present the results of a completed phase 2 open-label...
7.
Chowdary P, Alvarez-Roman M, Baghaei F, Klamroth R, Miesbach W, Blatny J
Haemophilia
. 2024 Dec;
PMID: 39642096
No abstract available.
8.
Albisetti M, Ardila J, Astermark J, Blatny J, Carcao M, Chowdary P, et al.
Haemophilia
. 2024 Dec;
PMID: 39642092
Introduction: Evidence-based clinical practice guidelines drive optimal patient care and facilitate access to high-quality treatment. Creating guidelines for rare diseases such as haemophilia, where evidence does not often come from...
9.
Chowdary P, Duran B, Batty P, Lowe G, Jones A, Pollard D, et al.
Haemophilia
. 2024 Nov;
31(1):26-38.
PMID: 39565651
Introduction: 2022 was a landmark year with two adeno-associated viral vectors (AAVs) receiving conditional marketing authorization from EMA for the treatment of persons with severe haemophilia A and severe to...
10.
Landoni G, Chowdary P, Meziani F, Creteur J, De Schryver N, Motsch J, et al.
Ann Intensive Care
. 2024 Nov;
14(1):170.
PMID: 39522090
Background: Pulmonary intravascular thrombus formation has been widely observed in patients with respiratory failure, for example, in patients with SARS-CoV-2 infection (COVID-19). The aim of this study was to evaluate...